These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 30885954

  • 1. Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes.
    Rotbain Curovic V, Theilade S, Winther SA, Tofte N, Eugen-Olsen J, Persson F, Hansen TW, Jeppesen J, Rossing P.
    Diabetes Care; 2019 Jun; 42(6):1112-1119. PubMed ID: 30885954
    [Abstract] [Full Text] [Related]

  • 2. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.
    Pilemann-Lyberg S, Hansen TW, Tofte N, Winther SA, Theilade S, Ahluwalia TS, Rossing P.
    Diabetes Care; 2019 Jun; 42(6):1088-1094. PubMed ID: 30885950
    [Abstract] [Full Text] [Related]

  • 3. Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes.
    Theilade S, Lyngbaek S, Hansen TW, Eugen-Olsen J, Fenger M, Rossing P, Jeppesen JL.
    J Intern Med; 2015 Mar; 277(3):362-371. PubMed ID: 24830873
    [Abstract] [Full Text] [Related]

  • 4. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P.
    Kidney Int; 2017 Nov; 92(5):1242-1248. PubMed ID: 28712855
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

  • 6. Risk of Rapid Kidney Function Decline, All-Cause Mortality, and Major Cardiovascular Events in Nonalbuminuric Chronic Kidney Disease in Type 2 Diabetes.
    Buyadaa O, Magliano DJ, Salim A, Koye DN, Shaw JE.
    Diabetes Care; 2020 Jan; 43(1):122-129. PubMed ID: 31796570
    [Abstract] [Full Text] [Related]

  • 7. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1265-1273. PubMed ID: 28495863
    [Abstract] [Full Text] [Related]

  • 8. Soluble urokinase-type plasminogen activator receptor and incident end-stage renal disease in Chinese patients with chronic kidney disease.
    Lv L, Wang F, Wu L, Wang JW, Cui Z, Hayek SS, Wei C, Reiser J, He K, Zhang L, Chen M, Zhao MH.
    Nephrol Dial Transplant; 2020 Mar 01; 35(3):465-470. PubMed ID: 30124995
    [Abstract] [Full Text] [Related]

  • 9. Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes.
    Barzilay JI, Davis BR, Ghosh A, Pressel SL, Rahman M, Einhorn PT, Cushman WC, Whelton PK, Wright JT, ALLHAT Collaborative Research Group.
    J Diabetes Complications; 2018 Sep 01; 32(9):830-832. PubMed ID: 30030011
    [Abstract] [Full Text] [Related]

  • 10. Cardio-Renal Biomarker Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated With Cardiovascular Death and Myocardial Infarction in Patients With Coronary Artery Disease Independent of Troponin, C-Reactive Protein, and Renal Function.
    Nikorowitsch J, Borchardt T, Appelbaum S, Ojeda F, Lackner KJ, Schnabel RB, Blankenberg S, Zeller T, Karakas M.
    J Am Heart Assoc; 2020 Apr 21; 9(8):e015452. PubMed ID: 32299288
    [Abstract] [Full Text] [Related]

  • 11. Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes.
    Theilade S, Hansen TW, Rossing P.
    Am J Hypertens; 2014 Sep 21; 27(9):1152-9. PubMed ID: 24627444
    [Abstract] [Full Text] [Related]

  • 12. Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy.
    Lajer M, Tarnow L, Jorsal A, Teerlink T, Parving HH, Rossing P.
    Diabetes Care; 2008 Apr 21; 31(4):747-52. PubMed ID: 18162497
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S, Lajer M, Jorsal A, Tarnow L, Parving HH, Rossing P.
    Diabet Med; 2012 Mar 21; 29(3):337-44. PubMed ID: 21988672
    [Abstract] [Full Text] [Related]

  • 14. Soluble urokinase plasminogen activator receptor in type 1 diabetic children, relation to vascular complications.
    Sherif EM, El Maksood AAA, Youssef OI, Salah El-Din NY, Khater OKM.
    J Diabetes Complications; 2019 Sep 21; 33(9):628-633. PubMed ID: 31301955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients.
    Rotbain Curovic V, Hansen TW, Eickhoff MK, von Scholten BJ, Reinhard H, Jacobsen PK, Persson F, Parving HH, Rossing P.
    Acta Diabetol; 2018 Nov 21; 55(11):1143-1150. PubMed ID: 30105469
    [Abstract] [Full Text] [Related]

  • 18. Arterial Stiffness Predicts Mortality in Individuals With Type 1 Diabetes.
    Tynjälä A, Forsblom C, Harjutsalo V, Groop PH, Gordin D, FinnDiane Study Group.
    Diabetes Care; 2020 Sep 21; 43(9):2266-2271. PubMed ID: 32647049
    [Abstract] [Full Text] [Related]

  • 19. Carotid-Femoral Pulse Wave Velocity as a Risk Marker for Development of Complications in Type 1 Diabetes Mellitus.
    Tougaard NH, Theilade S, Winther SA, Tofte N, Ahluwalia TS, Hansen TW, Rossing P, Frimodt-Møller M.
    J Am Heart Assoc; 2020 Oct 20; 9(19):e017165. PubMed ID: 32955366
    [Abstract] [Full Text] [Related]

  • 20. Soluble Urokinase-Type Plasminogen Activator Receptor, Changes of 24-Hour Blood Pressure, and Progression of Chronic Kidney Disease.
    Jhee JH, Nam BY, Lee CJ, Park JT, Han SH, Kang SW, Park S, Yoo TH.
    J Am Heart Assoc; 2021 Jan 05; 10(1):e017225. PubMed ID: 33325248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.